Notification of Preliminary Results

RNS Number : 9281A

Futura Medical PLC

26 February 2014

 



For immediate release

26 February 2014

Futura Medical plc

("Futura" or "the Company")

Notice of Preliminary Results

Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology will announce its preliminary results for the year ended 31 December 2013 on Friday 28 March 2014.

A briefing for analysts will be held at 10.00am on the morning of the results at the offices of Buchanan, 107 Cheapside, London EC2V 6DN.

For more information, or to register attendance, please contact Buchanan on 020 7466 5000.

For any further information, please contact:

Futura Medical plc
James Barder, Chief Executive	Tel: [phone]
mail to: [e-mail]	www.futuramedical.com
Cenkos Securities plc
Bobbie Hilliam	Tel: [phone]
For media enquiries, please contact:
Buchanan
Mark Court / Fiona Henson / Sophie Cowles	Tel: [phone]

Notes to Editors

Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com 

 

END

 

 

NORSEWFWIFLSEDE